Primidone

Product manufactured by Actavis Pharma, Inc.

Application Nr Approved Date Route Status External Links
ANDA083551 2005-02-24 Oral RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Primidone Tablets, Used Alone Or Concomitantly With Other Anticonvulsants, Are Indicated In The Control Of Grand Mal, Psychomotor, And Focal Epileptic Seizures. It May Control Grand Mal Seizures Refractory To Other Anticonvulsant Therapy.

All Formulated Excipients (5 Total)

Name Structure Kind Function Status
1. Silicon Dioxide SILICON DIOXIDE Unresolved AC-Anticaking agent , MISC-Miscellaneous , STAB-Stabilizer GRAS-Generally recognized as safe.
2. Docusate Sodium DOCUSATE SODIUM Molecular
3. Magnesium Stearate MAGNESIUM STEARATE Molecular AF-Antifoaming (or defoaming) agent , MISC-Miscellaneous REG-Food additives for which a petition has been filed and a regulation issued.
4. Cellulose, Microcrystalline CELLULOSE, MICROCRYSTALLINE Unresolved
5. Sodium Benzoate SODIUM BENZOATE Molecular

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Primidone PRIMIDONE ZINC1979

Comments